+36.1%
MRNA vs SPMO
+155.8%
-119.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SPMO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.5% | +4.9% | +5.1% |
| 7D | -1.1% | -0.9% | -0.1% | -0.6% |
| 30D | +126.1% | -1.9% | +128.0% | +127.1% |
| 3M | +190.0% | -1.4% | +191.4% | +184.0% |
| 6M | +157.2% | +25.5% | +131.7% | +106.0% |
| YTD | +388.2% | +24.8% | +363.4% | +293.0% |
| 1Y | +467.0% | +24.5% | +442.5% | +356.7% |
| 3Y | +36.1% | +157.1% | -121.1% | -36.7% |
| All | +36.1% | +155.8% | -119.7% | -36.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SPMO.
Daily Out/Under-Performance
Portfolio return minus SPMO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPMO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SPMO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling